UBE2I and tauopathy: Pharmacological inhibition of the SUMO-conjugating enzyme UBE2I was included because it demonstrated decreased information flow in P301S Tia1+/− versus P301S Tia1+/+ mice, but not PS19 versus WT mice, and thereby served as a useful comparison for distinguishing tauopathy versus TIA1-specific effects.